OneAscent Family Office’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Buy
936
+219
+31% +$224K 0.57% 39
2026
Q1
$660K Buy
717
+82
+13% +$83.1K 0.46% 49
2025
Q4
$683K Buy
635
+84
+15% +$80.3K 0.46% 56
2025
Q3
$420K Buy
551
+16
+3% +$11.9K 0.34% 76
2025
Q2
$417K Sell
535
-381
-42% -$296K 0.39% 61
2025
Q1
$752K Buy
916
+485
+113% +$404K 0.7% 41
2024
Q4
$332K Buy
+431
New +$357K 0.6% 41

Other funds holding LLY

OneAscent Family Office's LLY Position: Q2 2026 in Review

OneAscent Family Office increased its Eli Lilly (LLY) stake by 31% in Q2 2026, buying an estimated $224K and bringing the position to 936 shares worth $1.12M. The position accounts for 0.57% of the portfolio, ranked #39.

OneAscent Family Office first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • OneAscent Family Office held 936 shares of Eli Lilly worth $1.12M as of Q2 2026.
  • OneAscent Family Office bought 219 Eli Lilly shares in Q2 2026, an estimated $224K.
  • Eli Lilly made up 0.57% of OneAscent Family Office's portfolio in Q2 2026, its #39 holding.
  • OneAscent Family Office first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on OneAscent Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.